On 17 March, Verizon Communications Inc. (NYSE:VZ) shares increased 0.79% and was closed at $53.63. VZ EPS growth in last 5 year was 37.20%. Verizon Communications Inc. (NYSE:VZ) year to date (YTD) performance is 17.46%.
On 17 March, Verizon Communications Inc. (NYSE:VZ) said it will launch a buy-one, get-one-free promotion for the Samsung Galaxy S7 and S7 Edge this week, joining rivals T-Mobile (NYSE:TMUS) and AT&T (NYSE:T) in pushing the new, high-end phone.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares decreased -1.25% in last trading session and ended the day at $3.17. CLDX has a return on assets of -34.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -78.29%.
On 7 March, Celldex Therapeutics, Inc. (NASDAQ:CLDX) has announced the results of the second interim analysis for Act IV, the Phase 3 study of experimental cancer vaccine Rintega in newly diagnosed patients of EGFRvIII-positive glioblastoma, a form of brain tumor.
CM Finance Inc. (NASDAQ:CMFN) caters to the Financial space. Its weekly performance is 13.40%. On the last day of trading company shares ended up at $8.77. CM Finance Inc. (NASDAQ:CMFN) distance from 50-day simple moving average (SMA50) is 11.84%.
CM Finance Inc. (NASDAQ:CMFN) announced a cash dividend payment of $0.3516 per share is scheduled to be paid on April 07, 2016. Shareholders who purchased CMFN prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 1.35% increase over the prior quarter
Edison International (NYSE:EIX) shares increased 0.81% in last trading session and ended the day at $71.25. EIX Gross Margin is 63.00% and its has a return on assets of 2.00%. Edison International (NYSE:EIX) quarterly performance is 20.44%.
Edison International (NYSE:EIX) had its price target hoisted by SunTrust from $74.00 to $78.00 in a research report issued to clients and investors on Monday,StockTargetPrices.com reports. The firm presently has a “buy” rating on the stock. SunTrust’s target price indicates a potential upside of 11.38% from the company’s current price.
Trevena, Inc. (NASDAQ:TRVN) caters to the Healthcare space. Its weekly performance is -2.28%. On the last day of trading company shares ended up at $7.30. Trevena, Inc. (NASDAQ:TRVN) distance from 50-day simple moving average (SMA50) is 8.47%.
On 9 March, Trevena, Inc. (NASDAQ:TRVN) announced financial results for the fourth quarter and full year ended December 31, 2015 and provided an update regarding its ongoing clinical programs. For the fourth quarter of 2015, Trevena reported a net loss attributable to common stockholders of $15.5 million, or $0.30 per share, compared with a net loss attributable to common stockholders for the fourth quarter of 2014 of $13.3 million, or $0.45 per share.
Leave a Reply